The study conducted by Liu et al. investigated the role of NAMPT as a biomarker in esophageal squamous cell carcinoma, particularly in relation to obesity, chemotherapy response, and prognosis. This evidence concerns the gene NAMPT and obesity due to melanocortin 4 receptor deficiency.